Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study

Objective: The long-term outcome of children born to SLE mothers still represents a controversial topic in literature, with some studies reporting a possible increased prevalence of different neurologic and psychiatric diseases (NPD), including neurodevelopmental disorders (ND), and in particular le...

Full description

Bibliographic Details
Main Authors: Maria-Grazia Lazzaroni, Laura Andreoli, Francesca Crisafulli, Francesco Tamborini, Irene Debeni, Valentina Binda, Cecilia Nalli, Jessica Galli, Elisa Fazzi, Gabriella Moroni, Franco Franceschini, Angela Tincani
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.613239/full
id doaj-20573fbd6b6a4f228de8b2f9ce77b19a
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Maria-Grazia Lazzaroni
Maria-Grazia Lazzaroni
Laura Andreoli
Laura Andreoli
Francesca Crisafulli
Francesca Crisafulli
Francesco Tamborini
Irene Debeni
Valentina Binda
Cecilia Nalli
Jessica Galli
Jessica Galli
Elisa Fazzi
Elisa Fazzi
Gabriella Moroni
Franco Franceschini
Franco Franceschini
Angela Tincani
Angela Tincani
Angela Tincani
spellingShingle Maria-Grazia Lazzaroni
Maria-Grazia Lazzaroni
Laura Andreoli
Laura Andreoli
Francesca Crisafulli
Francesca Crisafulli
Francesco Tamborini
Irene Debeni
Valentina Binda
Cecilia Nalli
Jessica Galli
Jessica Galli
Elisa Fazzi
Elisa Fazzi
Gabriella Moroni
Franco Franceschini
Franco Franceschini
Angela Tincani
Angela Tincani
Angela Tincani
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study
Frontiers in Pharmacology
azathioprine
offspring
neurodevelopmental disorders
learning disabilities
pregnancy
systemic lupus erythematosus
author_facet Maria-Grazia Lazzaroni
Maria-Grazia Lazzaroni
Laura Andreoli
Laura Andreoli
Francesca Crisafulli
Francesca Crisafulli
Francesco Tamborini
Irene Debeni
Valentina Binda
Cecilia Nalli
Jessica Galli
Jessica Galli
Elisa Fazzi
Elisa Fazzi
Gabriella Moroni
Franco Franceschini
Franco Franceschini
Angela Tincani
Angela Tincani
Angela Tincani
author_sort Maria-Grazia Lazzaroni
title Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study
title_short Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study
title_full Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study
title_fullStr Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study
title_full_unstemmed Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study
title_sort neuropsychiatric outcome of children born to women with systemic lupus erythematosus and exposed in utero to azathioprine: a case-control study
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2020-12-01
description Objective: The long-term outcome of children born to SLE mothers still represents a controversial topic in literature, with some studies reporting a possible increased prevalence of different neurologic and psychiatric diseases (NPD), including neurodevelopmental disorders (ND), and in particular learning disorders (LD). Different risk factors have been advocated, such as the in utero exposure to auto-antibodies and drugs, particularly Azathioprine (AZA).Methods: A case-control study was designed to compare pregnancies treated with AZA (cases) with those not treated with AZA (controls). All the pregnancies had been prospectively followed in two Italian centers. The match was based upon renal involvement, antiphospholipid (aPL) status, maternal age at pregnancy (±5 years) and child’s age at the time of the study (±2 years). SLE mothers were interviewed by a telephone survey, particularly focused on the presence of a certified NPD in their children ≥6 years of age.Results: Twenty-seven cases and 65 controls were similar in terms of demographic, immunological and clinical features, except for a higher rate of SLE flares during pregnancy in cases (22.2% vs. 10.8%, p:0.191). The 92 children had a mean age of 14.0 years at the time of the survey; 11 had at least one NPD (12.0%). The frequency of each single NPD was similar to that of the general pediatric population and no association was found with either the in utero exposure to AZA, or other specific factors (auto-antibodies, disease activity, obstetric complications, prematurity).Conclusion: The long-term neuropsychiatric outcome of the children born to SLE mothers did not show neither an increased frequency of NPD as compared to the general pediatric population nor a specific pattern of NPD. The in utero exposure to AZA was not associated with the development of NPD in this case-control study of prospectively-followed pregnancies. NPD are complex conditions and large prospective studies are needed to capture the wide range of variables that may contribute to their development in the offspring of SLE women.
topic azathioprine
offspring
neurodevelopmental disorders
learning disabilities
pregnancy
systemic lupus erythematosus
url https://www.frontiersin.org/articles/10.3389/fphar.2020.613239/full
work_keys_str_mv AT mariagrazialazzaroni neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT mariagrazialazzaroni neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT lauraandreoli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT lauraandreoli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT francescacrisafulli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT francescacrisafulli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT francescotamborini neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT irenedebeni neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT valentinabinda neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT cecilianalli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT jessicagalli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT jessicagalli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT elisafazzi neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT elisafazzi neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT gabriellamoroni neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT francofranceschini neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT francofranceschini neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT angelatincani neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT angelatincani neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
AT angelatincani neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy
_version_ 1724381712782196736
spelling doaj-20573fbd6b6a4f228de8b2f9ce77b19a2020-12-16T05:27:16ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-12-011110.3389/fphar.2020.613239613239Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control StudyMaria-Grazia Lazzaroni0Maria-Grazia Lazzaroni1Laura Andreoli2Laura Andreoli3Francesca Crisafulli4Francesca Crisafulli5Francesco Tamborini6Irene Debeni7Valentina Binda8Cecilia Nalli9Jessica Galli10Jessica Galli11Elisa Fazzi12Elisa Fazzi13Gabriella Moroni14Franco Franceschini15Franco Franceschini16Angela Tincani17Angela Tincani18Angela Tincani19Department of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyRheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyRheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyRheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, ItalyNephrology Unit, IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyNephrology Unit, IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, ItalyRheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyNeuropsychiatry Unit, Children’s Hospital, ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyNeuropsychiatry Unit, Children’s Hospital, ASST Spedali Civili of Brescia, Brescia, ItalyNephrology Unit, IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyRheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyRheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, ItalyI.M. Sechenov First Moscow State Medical University, Moscow, RussiaObjective: The long-term outcome of children born to SLE mothers still represents a controversial topic in literature, with some studies reporting a possible increased prevalence of different neurologic and psychiatric diseases (NPD), including neurodevelopmental disorders (ND), and in particular learning disorders (LD). Different risk factors have been advocated, such as the in utero exposure to auto-antibodies and drugs, particularly Azathioprine (AZA).Methods: A case-control study was designed to compare pregnancies treated with AZA (cases) with those not treated with AZA (controls). All the pregnancies had been prospectively followed in two Italian centers. The match was based upon renal involvement, antiphospholipid (aPL) status, maternal age at pregnancy (±5 years) and child’s age at the time of the study (±2 years). SLE mothers were interviewed by a telephone survey, particularly focused on the presence of a certified NPD in their children ≥6 years of age.Results: Twenty-seven cases and 65 controls were similar in terms of demographic, immunological and clinical features, except for a higher rate of SLE flares during pregnancy in cases (22.2% vs. 10.8%, p:0.191). The 92 children had a mean age of 14.0 years at the time of the survey; 11 had at least one NPD (12.0%). The frequency of each single NPD was similar to that of the general pediatric population and no association was found with either the in utero exposure to AZA, or other specific factors (auto-antibodies, disease activity, obstetric complications, prematurity).Conclusion: The long-term neuropsychiatric outcome of the children born to SLE mothers did not show neither an increased frequency of NPD as compared to the general pediatric population nor a specific pattern of NPD. The in utero exposure to AZA was not associated with the development of NPD in this case-control study of prospectively-followed pregnancies. NPD are complex conditions and large prospective studies are needed to capture the wide range of variables that may contribute to their development in the offspring of SLE women.https://www.frontiersin.org/articles/10.3389/fphar.2020.613239/fullazathioprineoffspringneurodevelopmental disorderslearning disabilitiespregnancysystemic lupus erythematosus